Companie

Lupin posts net profit of ₹438.25 cr in December quarter

PTI New Delhi | Updated on January 29, 2021 Published on January 29, 2021

Pharma major Lupin has reported a consolidated net profit of ₹438.25 crore for the quarter ended December 31, 2020.

The company had posted a net loss of ₹835 crore for the corresponding period of the previous fiscal, Lupin said in a late night filing to the BSE.

Consolidated revenue from operations of the company stood at ₹3,917.30 crore for the quarter under consideration. It was at ₹3,716.09 crore for the same period a year ago, it added.

“We continue our trajectory of improved profitability and sustainable business growth. All our major businesses delivered robust growth amidst pandemic-related challenges and a weak flu season, reflecting the resilience of our business”, Lupin MD Nilesh Gupta said.

Shares of Lupin Ltd were trading at ₹1,020.95 per scrip on BSE, down 2.79 per cent from its previous close.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 29, 2021
BSE
pharmaceutical
Lupin Ltd
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.